Brivanib Attenuates Hepatic Fibrosis In Vivo and Stellate Cell Activation In Vitro by Inhibition of FGF, VEGF and PDGF SignalingIkuo Nakamura(Mayo Clinic), Lewis R. Roberts(Mayo Clinic)PLoS ONEApril 7, 201410.1371/journal.pone.0092273Cited by 61SaveCiteExport RISWatch citationsRelated PapersThe Transcription Factor GLI1 Mediates TGFβ1 Driven EMT in Hepatocellular Carcinoma via a SNAI1-Dependent Mechanism|PLoS ONE|2012|76Induction of Lysosome‐associated Protein Transmembrane 4 Beta via Sulfatase 2 Enhances Autophagic Flux in Liver Cancer Cells|Hepatology Communications|2019|13